Patients’ profile, burden of disease and quality of life in recurrent herpes labialis: a survey conducted in USA and France

医学 生活质量(医疗保健) 疾病 儿科 人口学 内科学 护理部 社会学
作者
Brigitte Dréno,Jean-Elie Malkin,Philippe Saïag,S. Batuji‐Garin
出处
期刊:Journal of The European Academy of Dermatology and Venereology [Wiley]
卷期号:26 (11): 1458-1460 被引量:16
标识
DOI:10.1111/j.1468-3083.2011.04348.x
摘要

Editor Herpes labialis (HL) is a very frequent disease that affects millions of people. In France, the HERPIMAX study reported a lifetime prevalence of 38.3% and the INSTANT study showed an annual prevalence of 14.8%.1 Although benign, HL is disabling and may have a significant impact on quality of life (QOL) as suggested by Lorette et al.1 The purpose of HERPESCOPE was to describe patients’ profiles, to understand the burden of disease and to assess the impact on QOL, in France and in the US. The HERPESCOPE, conducted by Nielsen, took place in November 2010. The sample was constituted according to the quotas method. All respondents, aged ≥18 years, were screened on having, themselves and/or their child, at least one episode of HL in the past 12 months. Patients having at least one episode in the last 4 weeks completed the QOL – SF-36 questionnaire.2–4 Comparisons were performed between patients with <4 episodes per year (CHL) and those with ≥4 episodes per year (FHL). A group of very frequent HL (VFHL ≥6) was individualized. 1002 and 1005 patients participated in the study and 437 and 476 completed the SF36 questionnaire, in the US and France, respectively. The profile of the patients was very similar to that established in INSTANT study,1 which confirms that there was no bias related to the sample profile (female patients: 59% and 58%, respectively, median class of ages 30–39 years). The mean annual numbers of episodes were high, respectively, 3.6 and 3.4. In both countries, FHL affects 35% of patients suffering from the disease (median of five episodes), and VFHL, 15% of them (median of eight episodes). In both countries, more than 75% of patients declared reacting during the prodromal phase, before redness appears (Table 1). In the US, FHL patients had earlier reactions than CHL patients (NS in France). The management of FHL and CHL patients was different. In both countries, for FHL patients the higher the number of episodes was, the higher the resort to physicians was (more marked in the US). In the US, FHL patients visited a doctor, or used an old prescription, more frequently than CHL patients (57% treated their herpes by themselves). In France, CHL patients asked a pharmacist’s advice (28%). HL episodes lead to frequent sick leaves, with longer durations in FHL groups. Among patients who followed a medical advice to treat their herpes, in US 45% stopped working due to their HL episode (33% with a sick leave, mostly among the FHL group; median duration: 5 and 3 days in the FHL and CHL groups, respectively) and in France 21% (14% with a sick leave; median duration: 5 and 3 days in the FHL and CHL groups, respectively). Quality of life, impaired in more than 80% of cases, is significantly more affected in FHL patients (Table 2). Approximately two-thirds of respondents reported an impact of their physical and/or emotional condition, more pronounced in FHL patients. A majority of patients were disturbed in their social life. Physical pain, reported by more than 90% of patients, was significantly more severe in the FHL groups. Physical pain had a negative effect on work and chores, the impact being significantly higher in FHL patients. Health condition limited patients in physical activity. The majority of patients were regularly tired or exhausted and the perception of their health was impaired in FHL patients. These results are consistent with those obtained in the Lorette study that showed significantly lower QOL scores in subjects with at least six episodes per year. These data reflect the burden of disease associated with HL.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
斯文的慕儿完成签到 ,获得积分10
1秒前
keen完成签到 ,获得积分10
1秒前
韭菜盒子完成签到,获得积分20
2秒前
潘特完成签到,获得积分10
3秒前
小彭友完成签到,获得积分10
14秒前
15秒前
josie完成签到 ,获得积分10
19秒前
llll完成签到 ,获得积分10
19秒前
量子星尘发布了新的文献求助10
19秒前
韭菜发布了新的文献求助10
19秒前
外向的斑马完成签到 ,获得积分10
20秒前
村长热爱美丽完成签到 ,获得积分10
22秒前
尹尹关注了科研通微信公众号
24秒前
呆呆完成签到 ,获得积分10
25秒前
xianyaoz完成签到 ,获得积分0
32秒前
杨远杰完成签到,获得积分10
33秒前
蓝桉完成签到 ,获得积分10
33秒前
JuliaWang完成签到 ,获得积分10
40秒前
无限的含羞草完成签到,获得积分10
41秒前
八二力完成签到 ,获得积分10
45秒前
韭菜发布了新的文献求助10
48秒前
情怀应助科研通管家采纳,获得30
51秒前
water应助科研通管家采纳,获得10
51秒前
JamesPei应助科研通管家采纳,获得10
51秒前
2012csc完成签到 ,获得积分0
53秒前
风清扬应助韭菜采纳,获得10
54秒前
WSY完成签到 ,获得积分10
55秒前
虞无声发布了新的文献求助10
56秒前
执着新蕾完成签到,获得积分10
58秒前
Vivian完成签到 ,获得积分10
1分钟前
666完成签到 ,获得积分10
1分钟前
1分钟前
量子星尘发布了新的文献求助10
1分钟前
蔡从安完成签到,获得积分10
1分钟前
奥雷里亚诺完成签到 ,获得积分10
1分钟前
不呆完成签到 ,获得积分10
1分钟前
Cheung2121发布了新的文献求助30
1分钟前
画龙完成签到,获得积分10
1分钟前
韭菜完成签到,获得积分20
1分钟前
Owen应助Cheung2121采纳,获得10
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038112
求助须知:如何正确求助?哪些是违规求助? 3575788
关于积分的说明 11373801
捐赠科研通 3305604
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022